KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Non-Current Liabilities (2016 - 2025)

West Pharmaceutical Services' Other Non-Current Liabilities history spans 16 years, with the latest figure at $65.7 million for Q1 2025.

  • For Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $65.7 million; the TTM value through Mar 2025 reached $65.7 million, changed N/A, while the annual FY2023 figure was $58.5 million, 13.37% up from the prior year.
  • Other Non-Current Liabilities for Q1 2025 was $65.7 million at West Pharmaceutical Services, up from $58.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $65.7 million in Q1 2025 and bottomed at $29.6 million in Q2 2021.
  • The 4-year median for Other Non-Current Liabilities is $38.2 million (2021), against an average of $45.1 million.
  • The largest annual shift saw Other Non-Current Liabilities crashed 31.8% in 2021 before it skyrocketed 35.08% in 2022.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $38.2 million in 2021, then surged by 35.08% to $51.6 million in 2022, then grew by 13.37% to $58.5 million in 2023, then grew by 12.31% to $65.7 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Other Non-Current Liabilities are $65.7 million (Q1 2025), $58.5 million (Q4 2023), and $51.6 million (Q4 2022).